Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded on February 12, 2026 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
72
Frequently Asked Questions
What is Market Cap of Hemab Therapeutics Holdings Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Hemab Therapeutics Holdings Inc. market cap is $60.59M.
What is the 52-week high for Hemab Therapeutics Holdings Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Hemab Therapeutics Holdings Inc. 52 week high is $36.61 as of May 03, 2026.
What is the 52-week low for Hemab Therapeutics Holdings Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Hemab Therapeutics Holdings Inc. 52 week low is $18.00 as of May 03, 2026.
What is Hemab Therapeutics Holdings Inc. stock price today?
Hemab Therapeutics Holdings Inc. stock price today is $34.00.
What was Hemab Therapeutics Holdings Inc. stock price yesterday?
Hemab Therapeutics Holdings Inc. stock price yesterday was $18.00.
What is the 50-day moving average of Hemab Therapeutics Holdings Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Hemab Therapeutics Holdings Inc. 50-day moving average is $26.00.
How many employees does Hemab Therapeutics Holdings Inc. have?
Hemab Therapeutics Holdings Inc. has 72 employees.